title: Do risks outweigh benefits in thrombolysis for stroke?
authors.affiliation: School of Primary, Aboriginal and Rural Health Care, University of Western Australia, Perth, Australia. simon.brown@uwa.edu.au
authors.forename: Simon G A
authors.initials: SG
authors.lastname: Brown
authors.forename: Stephen P J
authors.initials: SP
authors.lastname: Macdonald
authors.forename: Graeme J
authors.initials: GJ
authors.lastname: Hankey
mesh_terms: D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator